STOCK TITAN

Brandes discloses 29,126,291.55 GRFS ADRs; 19.6% ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Brandes Investment Partners, L.P. filed an amended Schedule 13G reporting beneficial ownership in Grifols SA. As of 09/30/2025, Brandes reports beneficial ownership of 29,126,291.55 ADRs, representing 19.6% of the class.

The filer reports no sole or shared voting power and shared dispositive power over 29,126,291.55 ADRs. Item 4 also notes holdings of 22,107,370 ordinary shares and 29,126,291.55 ADRs for which dispositive power is shared. The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



BRANDES INVESTMENT PARTNERS, LP
Signature:/s/ Glenn Carlson
Name/Title:Executive Director
Date:11/05/2025

FAQ

What did Brandes report in the GRFS Schedule 13G/A?

Brandes Investment Partners, L.P. reported beneficial ownership of 29,126,291.55 ADRs of Grifols SA, representing 19.6% of the class as of 09/30/2025.

What is the reported ownership percentage for GRFS?

Brandes reported a beneficial ownership of 19.6% of Grifols SA.

What voting power did Brandes disclose for GRFS?

Brandes reported 0 sole voting power and 0 shared voting power.

What dispositive power did Brandes report over GRFS securities?

Brandes reported shared dispositive power over 29,126,291.55 ADRs and noted holdings of 22,107,370 ordinary shares and 29,126,291.55 ADRs.

What is the event date for this GRFS ownership disclosure?

The date of the event requiring the filing is 09/30/2025.

How does this filing classify Brandes’s intent regarding control of GRFS?

The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control.
Grifols S A

NASDAQ:GRFS

GRFS Rankings

GRFS Latest News

GRFS Latest SEC Filings

GRFS Stock Data

6.29B
687.55M
57.63%
0.36%
Drug Manufacturers - General
Healthcare
Link
Spain
Barcelona